======= IP6K1 ======= == Gene Information == * **Official Symbol**: IP6K1 * **Official Name**: inositol hexakisphosphate kinase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9807|9807]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92551|Q92551]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IP6K1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IP6K1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606991|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). Converts 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4. |IPK| |inositol hexakisphosphate 3-kinase activity| |inositol hexakisphosphate 1-kinase activity| |inositol hexakisphosphate 5-kinase activity| |inositol hexakisphosphate kinase activity| |inositol phosphate biosynthetic process| |negative regulation of cold-induced thermogenesis| |phosphatidylinositol phosphorylation| |inositol phosphate metabolic process| |polyol biosynthetic process| |lipid phosphorylation| |polyol metabolic process| |alcohol biosynthetic process| |fibrillar center| |regulation of cold-induced thermogenesis| |phosphatidylinositol metabolic process| |organic hydroxy compound biosynthetic process| |lipid modification| |glycerophospholipid metabolic process| |alcohol metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |organic hydroxy compound metabolic process| |organophosphate biosynthetic process| |small molecule biosynthetic process| |organophosphate metabolic process| |cellular lipid metabolic process| |negative regulation of multicellular organismal process| |lipid metabolic process| |phosphorylation| |ATP binding| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp116|AICAR 240μM R03 exp116]]|-2.16| |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.06| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.04| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.91| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-1.85| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.84| |[[:results:exp16|DABN 2μM R00 exp16]]|-1.84| |[[:results:exp264|Arsenate 40μM R06 exp264]]|5.78| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.698| |[[:human genes:k:kidins220|KIDINS220]]|0.622| |[[:human genes:x:xpr1|XPR1]]|0.58| |[[:human genes:i:ip6k2|IP6K2]]|0.569| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17594 * **Expression level (log2 read counts)**: 5.73 {{:chemogenomics:nalm6 dist.png?nolink |}}